火针治疗斑块状银屑病血瘀证的多中心随机单盲试验方案
主要疗效指标为PASI评分,次要指标包括BSA、PGA、DLQI、PRQoL、瘙痒VAS、中医症状评分及复发率,旨在为火针治疗该证型的疗效与安全性提供高质量证据。
要点
- 火针治疗斑块状银屑病血瘀证的多中心随机单盲安慰剂对照试验方案。
- 主要疗效指标为PASI评分,次要指标涵盖BSA、PGA、DLQI、瘙痒VAS等。
核心结论
- 本方案拟通过多中心随机单盲安慰剂对照试验,为火针治疗斑块状银屑病血瘀证的疗效与安全性提供高质量证据。
研究设计与样本
- 患者随机分配至火针治疗组或火针对照组,每周治疗1次,共4周。
- 试验注册于ClinicalTrials.gov,注册号NCT03953885,注册日期2019年5月15日。
关键数值与推荐
- 主要疗效指标为PASI评分,次要指标包括BSA、PGA评分、DLQI评分、PRQoL、瘙痒VAS评分、中医症状评分及复发率。
- PASI评分、BSA、PGA评分和瘙痒VAS评分在基线和4周治疗及随访期间评估。
- DLQI评分、PRQoL和中医症状评分在基线和治疗期间评估,复发在随访期间评估。
- 安全性评估包括生命体征监测、血常规、血生化、尿常规、妊娠试验、体格检查和不良事件记录。
临床怎么用
- 若试验结果支持,火针疗法可能成为斑块状银屑病血瘀证的一种治疗选择,但需待本试验结果验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fire needle therapy is a characteristic treatment in traditional Chinese medicine (TCM). An increasing number of studies have indicated that fire needle treatment for psoriasis provides satisfactory results with few side effects and a low recurrence rate. We herein describe the protocol for a multicenter, randomized, single-blind, placebo-controlled trial that will provide high-quality evidence on the efficacy and safety of fire needle therapy for plaque psoriasis. METHODS: Ninety-two patients with blood stasis syndrome (BSS) of plaque psoriasis will be enrolled and randomly assigned to receive fire needle therapy (intervention group) or fire needle control therapy (control group) once a week for 4 weeks. The Psoriasis Area and Severity Index (PASI) score will serve as the major efficacy index, while the body surface area (BSA), Physician Global Assessment (PGA) score, Dermatology Life Quality Index (DLQI) score, patient-reported quality of life (PRQoL), visual analog scale (VAS) score for itching, TCM symptom score, and relapse rate will be assessed as secondary outcomes. The PASI score, BSA, PGA score, and VAS score for itching will be evaluated at baseline and during the 4-week treatment and follow-up periods. DLQI score, PRQoL, and TCM symptom score will be assessed at baseline and during the treatment period. Recurrence will be evaluated during the follow-up period. Safety assessments include vital sign monitoring, routine blood tests, blood biochemistry, routine urine tests, pregnancy tests, physical examinations, and adverse-event recording. SAS software will be used for data analysis. The data network platform will be designed by the data management center of Nanjing Ningqi Medical Technology Co., Ltd. DISCUSSION: It is believed that fire needle therapy can activate the meridians, promote blood circulation, and regulate skin immunity. BSS of plaque psoriasis is related to not only immune dysfunction but also poor or stagnant blood flow. We anticipate that the results of the trial described in this protocol will provide strong evidence for the safety and efficacy of fire needle therapy for BSS of plaque psoriasis. TRIAL REGISTRATION: Clinicaltrials.gov NCT03953885 . Registered on May 15, 2019. Name: Fire Needle Therapy on Plaque Psoriasis with Blood Stasis Syndrome.
引用
- Liu L, Lu Y, Yan XN, et al. Efficacy and safety of fire needle therapy for blood stasis syndrome of plaque psoriasis: protocol for a randomized, single-blind, multicenter clinical trial. Trials. 2020. PMID: 32843084. doi:10.1186/s13063-020-04691-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。